PreserVision AREDS 2 Formula

Using OCTA in optometric practice
Using OCTA in optometric practiceBy using OCTA technology, we are able to take better care of our patients with retinal disease, make smarter referrals, or be able to hold on to our patients, knowing a referral is not needed.
Future of ophthalmic innovation is through R&D partnershipsOphthalmology has benefitted from many innovative new therapies in recent years. How do we continue to drive innovation? And how can we, as an industry, accelerate bringing new therapies to the marketplace?